Event dossier

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.

1 report1 sourceJun 17, 2026, 5:03 PM
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

CNBCJun 17, 2026, 5:03 PM

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.